Vineet Laboratories Limited

BSE:543298 Stock Report

Market Cap: ₹463.3m

Vineet Laboratories Valuation

Is 543298 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 543298 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 543298's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 543298's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 543298?

Key metric: As 543298 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 543298. This is calculated by dividing 543298's market cap by their current revenue.
What is 543298's PS Ratio?
PS Ratio0.4x
Sales₹1.13b
Market Cap₹463.26m

Price to Sales Ratio vs Peers

How does 543298's PS Ratio compare to its peers?

The above table shows the PS ratio for 543298 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.5x
526345 Panjon
2.8xn/a₹435.8m
VIVIMEDLAB Vivimed Labs
0.2xn/a₹410.4m
524314 Gujarat Terce Laboratories
1.1xn/a₹574.5m
MEDIORG Medicamen Organics
1.9xn/a₹589.7m
543298 Vineet Laboratories
0.4xn/a₹463.3m

Price-To-Sales vs Peers: 543298 is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (2x).


Price to Sales Ratio vs Industry

How does 543298's PS Ratio compare vs other companies in the IN Pharmaceuticals Industry?

14 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.3.0x11.3%
543298 Vineet Laboratories
0.4xn/aUS$5.50m
NECLIFE Nectar Lifesciences
0.4xn/aUS$87.68m
539561 Remedium Lifecare
0.07xn/aUS$27.94m
543298 0.4xIndustry Avg. 3.0xNo. of Companies20PS02.44.87.29.612+
14 CompaniesEstimated GrowthMarket Cap
Industry Avg.3.0x17.8%
543298 Vineet Laboratories
0.4xn/aUS$5.50m
No more companies

Price-To-Sales vs Industry: 543298 is good value based on its Price-To-Sales Ratio (0.4x) compared to the Indian Pharmaceuticals industry average (3.1x).


Price to Sales Ratio vs Fair Ratio

What is 543298's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

543298 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.4x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 543298's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies